Denosumab and alendronate provide similar fracture outcomes: study
Better bone mineral density may not translate into fewer fractures
8th May 2019
Rates of osteoporotic fracture are similar three years after starting either denosumab or alendronate, according to a real-world Danish population-based cohort study.